Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM246 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BCL2L13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FARP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UNK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOSR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WNT5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01187 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
BBX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC36A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGMB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD300A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASEF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRICKLE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNTB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR137B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on